Related Experiment Video

Updated: May 28, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

β-blocker prevents sudden cardiac death in patients with hemodialysis

Yuya Matsue1, Makoto Suzuki, Wataru Nagahori

  • 1Division of Cardiology, Department of Medicine, Kameda Medical Center, 929 Higashi-chou, Kamogawa-shi, Chiba 296-8602, Japan. yuyam@kameda.jp

International Journal of Cardiology
|October 15, 2011
PubMed

Insights

Beta blockers significantly reduced sudden cardiac death (SCD) and overall mortality in hemodialysis patients. This suggests beta blockers may improve outcomes for this high-risk cardiovascular group.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pharmacology

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality in dialysis patients, with limited understanding of prevention strategies.
  • Cardiovascular disease is prevalent in patients undergoing maintenance hemodialysis, contributing to elevated mortality rates.
  • Beta blockers are known to prevent SCD in patients with cardiomyopathy or coronary artery disease.

Purpose of the Study:

  • To investigate the association between beta blocker use and the risk of sudden cardiac death (SCD) in patients undergoing maintenance hemodialysis.
  • To evaluate the impact of beta blockers on all-cause mortality in the hemodialysis population.

Main Methods:

  • A retrospective study analyzed data from 316 maintenance hemodialysis patients, followed for an average of 4.9 years until death.
  • Cox regression analysis was employed to adjust for potential confounders and determine the hazard ratio for beta blocker use.
  • Kaplan-Meier curves were utilized to compare survival rates between beta blocker and non-beta blocker groups.

Main Results:

  • Beta blocker use was associated with a significantly lower incidence of SCD (3.8% vs. 11.4%, P=0.047).
  • Patients on beta blockers experienced lower all-cause mortality rates (18.8% vs. 41.3%, P<0.001).
  • Cox regression revealed that beta blocker use was linked to a substantially reduced adjusted risk of SCD (HR, 0.201; P=0.011).

Conclusions:

  • Beta blocker administration in hemodialysis patients is associated with decreased risks of sudden cardiac death and overall mortality.
  • The findings suggest that beta blockers could be a valuable therapeutic strategy to improve clinical outcomes in this high-risk patient population.
Abstract

Related Concept Videos

Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Action of &#946;1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Adrenergic Antagonists: Pharmacological Actions of &#946;-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...